These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6505970)

  • 21. [Hürthle cell carcinoma of the thyroid. A 41 years experience].
    Sanz J; Cerpa F; Domínguez M; Franco C; Jadresic A; Pérez G; Phillipi V
    Rev Med Chil; 1999 Jul; 127(7):821-6. PubMed ID: 10668290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicular variant of papillary thyroid carcinoma: a long-term follow-up.
    Passler C; Prager G; Scheuba C; Niederle BE; Kaserer K; Zettinig G; Niederle B
    Arch Surg; 2003 Dec; 138(12):1362-6. PubMed ID: 14662540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy?
    McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A
    Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
    Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
    J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases].
    Pozzetto B; Roseano M; Dellach C; Leggeri A
    Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
    Włoch J; Czarniecka A; Turska M; Wilgus J
    Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial.
    Biermann M; Pixberg M; Riemann B; Schuck A; Heinecke A; Schmid KW; Willich N; Dralle H; Schober O;
    Nuklearmedizin; 2009; 48(3):89-98; quiz N15. PubMed ID: 19322503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: a 20-year review.
    Ley PB; Roberts JW; Symmonds RE; Hendricks JC; Snyder SK; Frazee RC; Smith RW; McKenney JF; Brindley GV
    Am Surg; 1993 Feb; 59(2):110-4. PubMed ID: 8476139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results in elderly patients with differentiated thyroid carcinoma.
    Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
    Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaplastic carcinoma of the thyroid.
    Hadar T; Mor C; Shvero J; Levy R; Segal K
    Eur J Surg Oncol; 1993 Dec; 19(6):511-6. PubMed ID: 8270035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
    Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatment of thyroid cancers with concurrent Graves disease.
    Chao TC; Lin JD; Chen MF
    Ann Surg Oncol; 2004 Apr; 11(4):407-12. PubMed ID: 15070601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differentiated cancers].
    Görtz G; Häring R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():961-6. PubMed ID: 1983687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differentiated thyroid carcinoma in childhood].
    Visa Zueras MT; Alonso Blanco M; Yturriaga Matarranz R; Ros Pérez P; Monroy Morante C; Sarriá Oses JM; Barrio Castellanos R
    An Esp Pediatr; 1992 Jul; 37(1):11-4. PubMed ID: 1416515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid cancer in children and adolescents in Denmark.
    Merrick Y; Hansen HS
    Eur J Surg Oncol; 1989 Feb; 15(1):49-53. PubMed ID: 2917665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.